Swapping Order of References in Non-Instituted Obviousness Combination Does Not Alter Scope of IPR Estoppel

Apr 19, 2018

Reading Time : 1 min

In Nox Medical EHF v. Natus Neurology Inc., defendant Natus had raised in an IPR petition certain obviousness combinations in the form of “A in view of B,” and the PTAB declined to institute those claims for review. Natus raised some of those same combinations before the district court, but changed which reference in the combination was “primary” and which was “secondary”—i.e., raising “B in view of A” before the district court when it had raised “A in view of B” in its IPR petition. Plaintiff Nox Medical moved in limine for an order barring Natus from raising these combinations as estopped under § 315(e)(2).

Judge Richard Andrews held that, “for the combinations that Defendant tried to raise in the IPR, but which the PT AB did not institute, Defendant may pursue the combinations at trial. For those combinations ‘A in view of B’ on which the PTAB did not institute, I would regard that as reasonably raising ‘B in view of A’ also, and thus I reject Plaintiff’s assertions to the contrary.”  Order at 2-3. In other words, under the court’s ruling, the ordering of references in an identical prior art combination is immaterial for purposes of estoppel under § 315(e)(2).

Nox Medical EHF v. Natus Neurology Inc., 1-15-cv-00709, Order (D. Del. April 12, 2018) (Andrews, J.)

Share This Insight

Previous Entries

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

IP Newsflash

March 12, 2026

The District of New Jersey recently denied the litigants’ request for a briefing schedule to resolve a dispute about a proposed discovery confidentiality order, and also denied extending the deadlines for the defendants’ invalidity and non-infringement contentions. At issue was the scope of the FDA and patent prosecution bars in the confidentiality order.

...

Read More

IP Newsflash

February 27, 2026

The USPTO Director denied a patent owner’s request for discretionary denial of two inter partes review (IPR) petitions, citing the petitioner’s “well-settled expectation” that it would not be accused of infringing the two challenged patents. The Director’s conclusion was based on the petitioner’s decade-long business relationship with the original owner of the challenged patents.

...

Read More

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.